Hexarelin


Overview

Hexarelin is the most potent growth hormone releasing peptide of the GHRP family per microgram — and the one with the most baggage. It produces the largest GH pulse, but also the strongest cortisol and prolactin elevation and the fastest receptor desensitization.

It has a genuine research pedigree: unlike most grey-market peptides, hexarelin has been administered to humans in published clinical studies, mostly as a GH stimulation test.

How It Works

Hexarelin acts through the ghrelin receptor (GHS-R1a) but also binds CD36 receptors in cardiac tissue — a unique property that gave it a research niche in cardiac protection, independent of GH release.

The desensitization problem

Continuous administration downregulates the GH response within weeks, faster than any other GHRP. Human studies show the GH pulse blunting substantially after 2-4 weeks of daily use. This makes hexarelin a short-cycle compound by design, not preference.

Key Benefits

Maximal GH pulse — the strongest acute GH release of the secretagogue family.

Cardiac protection — CD36-mediated cardioprotective effects in animal models, unique among GHRPs.

Fat metabolism — lipolytic effects documented in research settings.

Human data exists — rare for this class; dosing and effects are better characterized than most.

Side Effects & Considerations

Hexarelin has the worst off-target profile of the family: notable cortisol and prolactin elevation, water retention, and tingling. The rapid desensitization means longer is not better — it is simply less effective.

Verdict

For most goals, ipamorelin offers a better risk-benefit ratio, and GHRP-2 a similar punch with less baggage. Hexarelin remains a niche choice for short, aggressive cycles and for its unique cardiac research angle. Not approved for human therapeutic use; WADA prohibited.

Dosage protocols

Protocol Dosage Frequency Duration Notes
Short cycle (anecdotal) 100-200 mcg 1-2 times daily 2-4 weeks maximum Desensitization blunts effects after a few weeks — do not run long. Fasted administration.

Warnings

Strongest cortisol/prolactin elevation of the GHRP family. Rapid desensitization. Not approved for human use. WADA prohibited.